Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026
(NASDAQ: NRIX) Delayed: 18.49 -0.16 (0.86%)
Previous Close $18.65    52 Week High $ 
Open $18.49    52 Week Low $ 
Day High $18.95    P/E N/A 
Day Low $18.39    EPS $ 
Volume 153,502